Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Pfizer’s COVID-19 Pill Has Mixed Results for Healthcare ETFs By: ETF Trends November 05, 2021 at 16:29 PM EDT Pfizer (NYSE: PFE) is seeking FDA approval for a COVID-19 pill that is highly effective against severe cases of the coronavirus, lifting pharmaceutical sector-related exchange traded funds but dragging on biotech-related ETFs with exposure to some of the company’s biggest competitors. On... Read More >> Related Stocks: Nasdaq Biotechnology Ishares ETF US Pharmaceuticals Ishares ETF Vaneck Biotech ETF Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Pfizer’s COVID-19 Pill Has Mixed Results for Healthcare ETFs By: ETF Trends November 05, 2021 at 16:29 PM EDT Pfizer (NYSE: PFE) is seeking FDA approval for a COVID-19 pill that is highly effective against severe cases of the coronavirus, lifting pharmaceutical sector-related exchange traded funds but dragging on biotech-related ETFs with exposure to some of the company’s biggest competitors. On... Read More >> Related Stocks: Nasdaq Biotechnology Ishares ETF US Pharmaceuticals Ishares ETF Vaneck Biotech ETF